Abstract

The activation of phagocytes by lipopolysaccharide (LPS) has been implicated in the pathogenesis of Gram-negative sepsis. Although the interaction between CD14 and LPS is a key event in the signaling cascade, the molecular mechanism by which cellular activation occurs remains obscure. We hypothesized that the main function of CD14 was to bind LPS and transfer it to a second receptor, which then initiates the subsequent signal for cellular activation. Thus, surface binding of LPS to the cell membrane would be the critical step that CD14 carries out. To test this hypothesis, we examined the activity of two other proteins known to bind LPS, lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein. We found that when these normally soluble proteins were expressed in Chinese hamster ovary-K1 fibroblasts as glycosylphosphatidylinositol-anchored proteins, both could substitute for CD14 in initiating LPS signaling. Pharmacological studies with synthetic lipid A analogues demonstrated that these surface expressed LPS-binding proteins had characteristics that were qualitatively identical to membrane CD14. These data support the hypothesis that a receptor distinct from CD14 functions as the actual signal transducer and suggest that surface binding of LPS to the cell membrane is the crucial first step for initiating downstream signaling events.

Highlights

  • Mechanism by which LPS-induced cellular activation occurs

  • CHO-K1 fibroblasts were stably transfected with the three decay accelerating factor (DAF) plasmids to create the two experimental cell lines, CHO/lipopolysaccharide-binding protein (LBP) and CHO/bactericidal/permeability-increasing protein (BPI), and the control cell line, CHO/CD4

  • To assess the ability of the transfectants to bind LPS, CHO/ LBP, CHO/BPI, CHO/CD4 and CHO/CD14 were incubated with preformed complexes of boron dipyrromethane (BODIPY)-LPS and soluble CD14, an experimental technique that is thought to dissociate LPS aggregates into monomers [31]

Read more

Summary

To test the hypothesis that cellular binding alone of LPS

Membrane LPS-binding Proteins and Signaling would be sufficient to initiate cellular signaling, we constructed chimeric proteins consisting of LBP or BPI attached to the GPI anchor of decay accelerating factor (DAF) [24, 25]. Expression of these constructs would create an artificial LPS receptor on the surface of the transfected cell. We found that CHO-K1 fibroblasts expressing GPI-anchored LBP or BPI could bind both LPS and Gram-negative bacteria They could initiate the LPS signaling cascade in a CD14-independent manner, similar to CD11/CD18-transfected cell lines. We conclude from this that the ability of an LPS binding protein to focus LPS on the surface membrane of a cell, where it can interact with a second receptor, is sufficient to activate the specific LPS-signaling apparatus

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.